Why Meridian Bioscience's Shares Are Rising Today? Vandana Singh February 4, 2022 VIVO View more earnings on VIVO See more from Benzinga Delcath's Chemosat Hepatic Delivery System Shows Overall Response Rate Of 60.5% In Eye Cancer That Spreads To Liver Valneva - Pfizer Choose Three-Dose Schedule For Lyme Vaccine Candidate Moving Forward © 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. View Comments Terms and Privacy Policy Privacy Dashboard More Info